These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug target gene-based analyses of drug repositionability in rare and intractable diseases. Sakate R; Kimura T Sci Rep; 2021 Jun; 11(1):12338. PubMed ID: 34117295 [TBL] [Abstract][Full Text] [Related]
4. A new toolkit for conducting clinical trials in rare disorders. Abrahamyan L; Diamond IR; Johnson SR; Feldman BM J Popul Ther Clin Pharmacol; 2014; 21(1):e66-78. PubMed ID: 24671886 [TBL] [Abstract][Full Text] [Related]
5. Drug approvals 2011: focus on companion diagnostics. Goozner M J Natl Cancer Inst; 2012 Jan; 104(2):84-6. PubMed ID: 22215850 [No Abstract] [Full Text] [Related]
6. Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases. Bollyky TJ; Cockburn IM; Berndt E Clin Trials; 2010 Dec; 7(6):719-34. PubMed ID: 21109581 [TBL] [Abstract][Full Text] [Related]
7. A father's fight to help his sons - and fix clinical trials. Adam D Nature; 2019 Jan; 565(7738):148-151. PubMed ID: 30626961 [No Abstract] [Full Text] [Related]
8. A new toolkit for conducting clinical trials in rare disorders: will this dog hunt? Peterson RG; Macleod SM; Klein AV J Popul Ther Clin Pharmacol; 2014; 21(1):e79-80. PubMed ID: 24671905 [No Abstract] [Full Text] [Related]
16. More support for clinical trials in children. Nature; 2016 Jul; 535(7613):465-6. PubMed ID: 27466087 [No Abstract] [Full Text] [Related]
17. [Benefit assessment in special situations--rare diseases]. Windeler J; Lange S Z Evid Fortbild Qual Gesundhwes; 2008; 102(1):25-30. PubMed ID: 19009938 [TBL] [Abstract][Full Text] [Related]
18. Power of rare diseases: found in translation. Fishman MC Sci Transl Med; 2013 Sep; 5(201):201ps11. PubMed ID: 24005157 [TBL] [Abstract][Full Text] [Related]
19. Genetic convergence of rare lymphomas. Shingleton JR; Dave SS Curr Opin Hematol; 2018 Jul; 25(4):307-314. PubMed ID: 29702524 [TBL] [Abstract][Full Text] [Related]
20. Statistical considerations for rare diseases drug development. Chow SC; Chang YW J Biopharm Stat; 2019; 29(5):874-886. PubMed ID: 31454299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]